554
Views
5
CrossRef citations to date
0
Altmetric
Oncology

Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States

ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 1599-1607 | Received 05 Mar 2021, Accepted 17 May 2021, Published online: 18 Jun 2021

References

  • STD facts – human papillomavirus (HPV) [Internet]. [cited 2020 Nov 10]. Available from: https://www.cdc.gov/std/hpv/stdfact-hpv.htm.
  • Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107:djv086.
  • Van Dyne EA, Henley SJ, Saraiya M, et al. Trends in human papillomavirus–associated cancers — United States, 1999–2015. MMWR Morb Mortal Wkly Rep. 2018;67(33):918–924.
  • Centers for Disease Control and Prevention. Cancers associated with human papillomavirus, United States—2011–2015 USCS data brief, no. 4. Atlanta, GA: Centers for Disease Control and Prevention. 2018.
  • Senkomago V, Henley SJ, Thomas CC, et al. Human papillomavirus–attributable cancers — United States, 2012–2016. MMWR Morb Mortal Wkly Rep. 2019;68(33):724–728.
  • Centers for Disease Control and Prevention (CDC) D of CP and C. Cancers associated with human papillomavirus, United States, 2013–2017 [Internet]; 2020. Available from: https://www.cdc.gov/cancer/uscs/pdf/USCS-DataBrief-No18-September2020-h.pdf.
  • Chesson HW, Meites E, Ekwueme DU, et al. Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States. Hum. Vaccines Immunother. 2019;15:1942–1948.
  • Hu D, Goldie S. The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol. 2008;198:500.e1-7.
  • Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998–2003. Cancer. 2008;113(S10):2855–2864.
  • Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Heal United States. 2010;46(4):S20–S26.
  • Saraiya M, Watson M, Wu X, et al. Incidence of in situ and invasive vulvar cancer in the US, 1998–2003. Cancer. 2008;113(S10):2865–2872.
  • Fu S, Lairson DR, Chan W, et al. Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas. Gynecol. Oncol. 2018;148:342–348.
  • Wu CF, Xu L, Fu S, et al. Health care costs of anal cancer in a commercially insured population in the United States. J Manag Care Spec Pharm. 2018;24:1156–1164.
  • Lairson DR, Fu S, Chan W, et al. Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas. Gynecol Oncol. 2017;145(1):108–113.
  • Lairson DR, Wu CF, Chan W, et al. Mean treatment cost of incident cases of penile cancer for privately insured patients in the United States. Urol. Oncol. Semin. Orig. Investig. 2019;37:294.e17–294–e25.
  • Lairson DR, Wu CF, Chan W, et al. Medical care cost of oropharyngeal cancer among Texas patients. Cancer Epidemiol Biomarkers Prev. 2017;26:1443–1449.
  • Chuang LT, Temin S, Camacho R, et al. Management and care of women with invasive cervical cancer: American Society of Clinical Oncology Resource-stratified clinical practice guideline. J Glob Oncol. 2016;2:311–340.
  • Stevanović S, Draper LM, Langhan MM, et al. Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. J Clin Oncol. 2015;33:1543–1550.
  • Menderes G, Black J, Schwab CL, et al. Immunotherapy and targeted therapy for cervical cancer: an update. Expert Rev Anticancer Ther. 2016;16(1):83–98.
  • Marret G, Borcoman E, Le Tourneau C. Pembrolizumab for the treatment of cervical cancer. Expert Opin Biol Ther. 2019;19:871–877.
  • Ghosn M, Kourie HR, Abdayem P, et al. Anal cancer treatment: current status and future perspectives. World J Gastroenterol. 2015;21(8):2294–2302.
  • Gunaseelan V, Kenney B, Lee JSJ, et al. Databases for surgical health services research: clinformatics Data Mart. Surg. 2019;165(4):669–671.
  • Parsons LS. Performing a 1: N case-control match on propensity score. Proceedings of 29th Annual SAS Users Group International Conference. 2004.
  • Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol. 2000;29(5):891–898.
  • Consumer price index-medical care [Internet] [cited 2019 Feb 15]. Available from: https://data.bls.gov/cgi-bin/surveymost?cu.
  • Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38(6):1228–1234.
  • Viens LJ, Henley SJ, Watson M, et al. Human papillomavirus–associated cancers — United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661–666.
  • Hayes C, Bhandari N, Kathe N, et al. Reliability and validity of the medical outcomes study short form-12 version 2 (SF-12v2) in adults with non-cancer pain. Healthcare. 2017;5(2):22.
  • Chesson HW, Ekwueme DU, Saraiya M, et al. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine. 2012;30:6016–6019.
  • Chen X, Afanador NL, Chen J, et al. Develop a machine learning application to predict patient risk of nonadherence toward metformin in type-2 diabetes management from US claims databases. American Diabetes Association. 79th Scientific Sessions. San Franciso, CA, USA; 2019.
  • Shao C, He J, Stein K, et al. Chemotherapy treatments, costs of care, and survival for elderly patients diagnosed with cervical cancer: an observational study. Curr Med Res Opin. 2020;36(7):1187–1194.
  • Deshmukh AA, Zhao H, Franzini L, et al. Total lifetime and cancer-related costs for elderly patients diagnosed with anal cancer in the United States. Am J Clin Oncol Cancer Clin Trials. 2018;41:121–127.
  • Petrosky E, Bocchini JA, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300–304.
  • Markowitz LE, Gee J, Chesson H, et al. Ten years of human papillomavirus vaccination in the United States. Acad Pediatr. 2018;18(2S):S3–S10.
  • American Cancer Society. Cancer facts & figures [Internet]. Cancer Facts. 2017 [cited 2020 Nov 21]. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.